Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
Twist Bioscience Corporation (NASDAQ:TWST) is one of the best performing healthcare stocks so far in 2026.
Twist Bioscience Corp (TWST)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 6,342,733 | $301,406,681 | -17% | 2.34% |
| 2. | Farallon Capital Thomas Steyer | 1,427,650 | $67,841,928 | +18563% | 0.39% |
| 3. | Soleus Capital Guy Levy | 1,226,629 | $58,289,410 | -35% | 2.36% |
| 4. | Citadel Investment Group Ken Griffin | 1,220,400 | $57,993,408 | +3708% | 0.01% |
| 5. | Tao Capital Nicholas J. Pritzker | 828,815 | $39,385,289 | 33.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.20 | 10,000 | $132,000.00 | 29,297 | 2023-05-10 | Filing | |
| $29.25 | 8,550 | $250,096.05 | 13,939 | 2022-05-11 | Filing | |
| $14.00 | 60,000 | $840,000.00 | 954,146 | 2018-11-02 | Filing | |
| $14.00 | 15,000 | $210,000.00 | 2,407,422 | 2018-11-02 | Filing | |
| $14.00 | 60,000 | $840,000.00 | 954,146 | 2018-11-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.12 | 12,000 | $673,440.00 | 17,754 | 2026-05-12 | Filing | |
| $56.88 | 4,961 | $282,186.64 | 49,674 | 2026-05-08 | Filing | |
| $57.15 | 1,962 | $112,125.95 | 135,941 | 2026-05-04 | Filing | |
| $57.15 | 5,127 | $293,001.90 | 853,760 | 2026-05-04 | Filing | |
| $57.15 | 2,844 | $162,531.19 | 278,964 | 2026-05-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,367,777 | $302,596,753 | 0.49% | |
| 2. | 5,554,362 | $263,943,282 | 0% | |
| 3. | 5,382,521 | $255,777,398 | 2.05% | |
| 4. | 5,269,718 | $250,416,999 | 0.83% | |
| 5. | 3,670,682 | $174,430,809 | 0.01% |
News See All
10 Best Performing Healthcare Stocks So Far in 2026
She was of the view that the backdrop at present is featuring geopolitical tensions, Fed policy uncertainty, inflation concerns, and still, it is incredible that the stock market is at record highs.
Twist Bioscience Corp (TWST) Climbed on Earnings Beat
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download here.
Twist Bioscience Corp. (TWST) Rallied on Record-Breaking Quarterly Report
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2026 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2026 Earnings Call Transcript May 4, 2026Twist Bioscience Corporation misses on earnings expectations.
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026Twist Bioscience Corporation misses on earnings expectations.
Twist Bioscience Corporation (TWST): A Bull Case Theory
We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will summarize the bulls’ thesis on TWST.
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)
TheFly reported on December 15, 2025, that Barclays kept its Overweight rating and boosted its price objective for Twist Bioscience Corporation (NASDAQ:TWST) from $37 to $39.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
7 Most Promising Gene Editing Stocks According to Analysts
Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, delete, or modify DNA within living cells.
Hedge Fund Resource Center